Share this video  

ASCO GI 2022 | Combining immunotherapy and chemotherapy in rectal cancer

Ali Shamseddine, MD, American University of Beirut, Beirut, Lebanon, explains how there are many Phase II trials investigating the use of immunotherapy with chemotherapy in patients with rectal cancer but there is currently no method of selection for patients who will benefit from this combination. This interview took place at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022